Publicacións (529) Publicacións nas que participase algún/ha investigador/a

2022

  1. "the red cage": Implementation of pH-responsiveness within a macrobicyclic pyridinium-based molecular host

    Organic Chemistry Frontiers, Vol. 9, Núm. 1, pp. 81-87

  2. "vermellogens" and the Development of CB[8]-Based Supramolecular Switches Using pH-Responsive and Non-Toxic Viologen Analogues

    Journal of the American Chemical Society, Vol. 144, Núm. 41, pp. 19127-19136

  3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

    Revista espanola de cardiologia (English ed.), Vol. 75, Núm. 6, pp. 523

  4. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC

    European journal of heart failure, Vol. 24, Núm. 1, pp. 4-131

  5. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC

    Cor et Vasa, Vol. 64, pp. 4-55

  6. 3D printed carboxymethyl cellulose scaffolds for autologous growth factors delivery in wound healing

    Carbohydrate Polymers, Vol. 278

  7. 48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort

    PLoS ONE, Vol. 17, Núm. 11 November

  8. @thermogramer: Thermal Imaging as a Tool for Science Communication and E-Learning in Social Media

    Sustainability (Switzerland), Vol. 14, Núm. 5

  9. A Broad-Host-Range Plasmid Outbreak: Dynamics of IncL/M Plasmids Transferring Carbapenemase Genes

    Antibiotics, Vol. 11, Núm. 11

  10. A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice

    Vaccines, Vol. 10, Núm. 6

  11. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  12. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC-HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 335-350

  13. A lack of timing-dependent effects of transcranial direct current stimulation (tDCS) on the performance of a choice reaction time task

    Neuroscience Letters, Vol. 782

  14. A novel Troponin I mutation associated with severe restrictive cardiomyopathy - A case report of a 27-year-old woman with fatigue

    European Heart Journal - Case Reports, Vol. 6, Núm. 2

  15. A pilot randomized controlled trial of aquatic-based activities in a group occupational therapy program for adults living with serious mental illness in Spain

    Health and Social Care in the Community, Vol. 30, Núm. 4, pp. e1364-e1374

  16. A pooled analysis of molecular epidemiological studies on modulation of DNA repair by host factors

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 876-877

  17. A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

    Annals of Oncology, Vol. 33, Núm. 2, pp. 181-192

  18. A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

    Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

  19. A red flag before patent foramen ovale closure: recognizing the incomplete cor triatriatum dexter

    International Journal of Cardiovascular Imaging, Vol. 38, Núm. 1, pp. 113-115

  20. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort

    European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801